In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.
This project comprises the development of a novel Dutch biobanking standard as a fully revised update of the Parelsnoer document that has been used in Dutch UMC’s for clinical biobanking since 2015. The project is led by a 3 member executive committee, that includes professor Dorine Swinkels from the Radboud Biobank.
Garbage in is garbage out. An important prerequisite for obtaining reliable results in biomedical research is the quality of the biomaterials. Low sample quality and variations therein can lead to undesirable post-analytic outcomes, potentially leading to incorrect conclusions and thereby, research waste. Therefore, collection, processing and storage (pre-analysis) of these materials needs to be evidence based to ensure fitness for its future purpose, and needs to be harmonized between biobanks and well documented.
The Parelsnoer standard is a solid guideline for the pre-analysis of biobanks. At the same time this standard needs a thorough revision that is more in line with the recent international developments on sustainability and research with stored biomaterials and as such better serves the needs of high quality and reproducible medical research in the Netherlands.
The project will run until 2026 and aims to develop and implement an evidence-based, fit-for-purpose biobanking standard for various biomaterials for health care research in the Netherlands. The project also aims to create awareness about the importance of pre-analytic standardization within the work field and to stimulate a collective responsibility for pre-analytics . Standards will be developed together with experts on current practice, using a pre-defined Delphi methodology based on scientific evidence for a wide range of human biomaterials commonly used in biomedical research. Implementation of the standards will be carried out with stakeholders representing professionals and users in health care and medical research. The implementation of this biobanking standard shall improve quality and interoperability of biomaterials used for health research innovation and decrease research waste.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
One year since the new business model for the Radboud Biobank was implemented
3 March 2026The new business model was introduced last year, with departments paying half of the biomaterial processing costs, covering the storage costs, and applying a graduated rate for sample issuance.
go to page
Periodic invoicing biobank collections
3 March 2026Since 2025, the Radboud Biobank periodically charges all biobank collections for the processing and storage costs incurred.
go to page
The purpose of a central biobank facility such as the Radboud Biobank
3 March 2026As the central biobank facility of Radboudumc, the Radboud Biobank does more than simply store human biomaterials.
go to page
Radboud Biobank's 2025 annual report
3 March 2026The Radboud Biobank's 2025 annual report is now available on request.
go to page
Aevai Health developed a virtual assistant
3 March 2026Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.
go to page
Radboudumc Researchers Highlight Critical Gaps in Reporting Pre-Analytical Processes in Biobanked Biomaterials
21 October 2025Radboudumc Researchers have identified significant shortcomings in pre-analytical sample processing reporting in clinical biomarker research, a factor crucial for study reliability and replicability.
go to page